Introduction
============

The catalytic enantioselective construction of a quaternary stereogenic center continues to be a challenging issue in organic synthesis ([Fig. 1](#fig1){ref-type="fig"}).[@cit1] One of the conventional methods for constructing the quaternary stereogenic center is nucleophilic addition to a polarized double bond, such as C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000O, C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000N, or C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000C, having two substituents at the addition site. In fact, the enantioselective nucleophilic addition to a ketone (C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000O) or a ketimine (C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000N) as an electrophile has been extensively investigated and a wide variety of chiral catalysts have been employed to control the stereochemical outcome of the addition products in an enantioselective manner ([Fig. 1a](#fig1){ref-type="fig"}).[@cit2] Among established approaches, organocatalytic protocols have drawn much attention in terms of metal-free conditions.[@cit3] However, in general, ketones and ketimines are intrinsically less reactive than their corresponding aldehydes and aldimines due to steric congestion at the reaction site. To enhance the reactivity of these electrophiles, functional and structural modifications, for instance, the introduction of an electron-withdrawing group or a ring system, are necessary. In this regard, electrophiles that are applicable to these nucleophilic additions are rather limited particularly in organocatalytic processes.[@cit2b],[@cit4] In contrast to these conventional methods, we have directed our attention to an allylic substitution reaction, namely, the S~N~2′ reaction, which is initiated by the activation of a leaving group using a Brønsted acid catalyst, as an alternative and efficient method for the construction of a quaternary stereogenic center ([Fig. 1b](#fig1){ref-type="fig"}). We have anticipated that the allylic substitution reaction under acidic conditions would proceed through a positively charged transition state and hence the introduction of multiple substituents to the reaction site would lead to the stabilization of the transition state, which in turn would facilitate the formation of a tetra-substituted carbon center, despite the increase in steric congestion around the reaction site. In addition, the relative position of the leaving group to the substituents at the reaction site is apparently defined by the geometry of the double bond by which these two substituents are discriminated, *i.e.*, near the leaving group side, R^1^, and far from it, R^2^ ([Fig. 1b](#fig1){ref-type="fig"}). It can be considered that the discrimination of these two substituents at the reaction site is the key to achieving high enantioselectivity. Consequently, the proposed method is quite feasible for constructing a quaternary stereogenic center in an enantioselective manner. Indeed, it was accomplished by means of an intramolecular S~N~2′ reaction using a chiral Brønsted acid catalyst. We disclose herein the developed method in detail and discuss the mechanistic insight into the present S~N~2′ reaction on the basis of experimental and theoretical studies.

![Enantioselective construction of quaternary stereogenic center *via* nucleophilic addition *vs.* nucleophilic substitution.](c8sc01942h-f1){#fig1}

Results and discussion
======================

Reaction system to be established
---------------------------------

The asymmetric allylic substitution reaction, represented by the Tsuji--Trost reaction, has been intensively investigated and a number of examples using chiral catalysts, including transition metals and Lewis acids, have been reported to date.[@cit5],[@cit6] In contrast, the use of a chiral Brønsted acid catalyst,[@cit7] namely, a metal-free process, has largely been unexplored[@cit8] and no example has been reported for the catalytic *enantio*-control of the quaternary stereogenic center despite the marked benefits of the proposed allylic substitution reaction. In this context, taking advantage of the allylic substitution reaction *via* the activation of the leaving group by a chiral Brønsted acid catalyst, we envisioned a novel approach to the enantioselective construction of a quaternary stereogenic center under metal-free conditions.

To validate the proposed method, we employed allylic substrate **1** having trichloroacetimidate moieties at both ends of the allylic position ([Scheme 1](#sch1){ref-type="fig"}), which can be readily prepared from butyne diol in two steps in the geometrically pure (*E*)-form.[@cit9] Under acidic conditions, bis-trichloroacetimidate **1** undergoes the S~N~2′ reaction, in which one of the trichloroacetimidate moieties functions as a leaving group whereas the other is utilized as a nucleophile. The reaction is capable of an intramolecular process in which the leaving group and the nucleophilic moiety are assembled into a geometrically well-arranged system and the substitution mode is restricted to an S~N~2′ fashion. More importantly, despite expecting the formation of regioisomers **2** and **2′** principally in the proposed system, it can be anticipated that the nucleophilic substitution reaction would predominantly proceed through the multi-substituted site, affording regioisomer **2** having a quaternary stereogenic center, because of resonance stabilization of the positively charged transition state by additional substituent R. In this context, bis-trichloroacetimidate **1** (R ≠ H) is an ideal substrate for the enantioselective construction of the quaternary stereogenic center under acidic conditions.

![Enantioselective allylic substitution reaction of bis-trichloroacetimidate **1** catalyzed by chiral phosphoramide derivative **3**.](c8sc01942h-s1){#sch1}

Transition metal complexes as well as achiral Lewis and Brønsted acids have been used as efficient catalysts for this type of transformation.[@cit10] In addition, an enantioselective variant using a chiral palladium catalyst has been reported,[@cit11] although substrate **1** has no substituent (R = H) at the vinyl position, affording the product having a tertiary stereogenic center. It should be emphasized here that the *enantio*-control of the quaternary stereogenic center has never been reported despite providing a practical access to synthetically useful amino alcohol derivatives **2** (R ≠ H) in an *enantio*-enriched form. We successfully demonstrated that chiral phosphoramide derivative **3** functioned as an efficient catalyst for the intramolecular S~N~2′ reaction of bis-trichloroacetimidate **1**, affording *enantio*-enriched amino alcohol derivatives **2** bearing a quaternary stereogenic center (R ≠ H). Furthermore, the mechanistic elucidation of the present S~N~2′ reaction was also thoroughly investigated. It was experimentally and theoretically clarified that the reaction proceeded through synchronous *anti*-S~N~2′ pathway **A**, as illustrated in [Scheme 1](#sch1){ref-type="fig"}, whereas the formation of phosphorimidate ester **B** was also detected by ^1^H and ^31^P NMR measurements during the course of the allylic substitution reaction. However, ester **B**, which was generated by the nucleophilic substitution reaction, namely, the S~N~2 reaction, of catalyst **3** with **1** at the terminal allylic position far from R group, was proven to be the less active species. Thus, catalyst **3** was deactivated by this side reaction, although covalently linked phosphate esters were recently reported as an active intermediate in chiral phosphoric acid catalysis.[@cit12] The proposed reaction pathway, which involves the deactivation pathway, was also confirmed by theoretical studies of a model system. These theoretical studies also indicated that the sulfonamide unit introduced to the phosphorus center is the key to accelerating the proposed synchronous *anti*-S~N~2′ reaction through transition state **A**. Thus, the oxygen atom of the sulfonamide group interacts with the proton attached to the nucleophilic imidate moiety through the hydrogen bond and increases the nucleophilicity of the nitrogen atom N~*Nu*~. Prior to the activation of the nucleophilic site N~*Nu*~, the *anti*-S~N~2′ reaction is initiated through the protonation of imidate nitrogen N~*LG*~ of the leaving group by the acidic H--O moiety of **3**, giving rise to the substitution product **2** in a highly enantioselective manner in most cases.

Optimization of reaction conditions and chiral phosphoric acid catalyst
-----------------------------------------------------------------------

Initially, chiral phosphoric acid **4** (G = anthryl) was employed to confirm the efficiency of the parent catalyst. As shown in [Table 1](#tab1){ref-type="table"}, the reaction of geometrically pure (*E*)-**1a** was conducted using catalyst (*R*)-**4** (10 mol%) in dichloromethane at room temperature. However, only a trace amount of substitution product **2a** was formed presumably due to the low acidity of catalyst **4** ([Table 1](#tab1){ref-type="table"}, entry 1).[@cit13] In order to enhance the acidity of the catalyst, we employed phosphoramide derivative (*R*)-**3**.[@cit14] As expected, catalyst **3a** having a triflate group, the most representative phosphoramide catalyst having a high acidity, accelerated the reaction markedly in dichloromethane at room temperature. Desired cyclized product **2a** bearing a quaternary stereogenic center was obtained exclusively in good yield and no regioisomer **2a′** was formed at all, *albeit* the low enantioselectivity (27% ee) ([Table 1](#tab1){ref-type="table"}, entry 2).[@cit15] Further screening for the reaction solvent revealed that chloroform was best in terms of catalytic efficiency and slight enhancement of the enantioselectivity was detected ([Table 1](#tab1){ref-type="table"}, entries 3--5), although it was still not high enough (36% ee). Lowering the reaction temperature to --40 °C dramatically enhanced the enantioselectivity (80% ee) ([Table 1](#tab1){ref-type="table"}, entry 6). However, a significant amount of starting bis-trichloroacetimidate **1a** remained unchanged even after 24 h. This serious problem was surmounted by adding molecular sieves (MS) 4A ([Table 1](#tab1){ref-type="table"}, entry 7)[@cit16] and product **2a** was formed in excellent yield within 6 h without marked loss of enantioselectivity ([Table 1](#tab1){ref-type="table"}, entry 7 *vs.* 6). In the presence of MS 4A, catalyst loading could be reduced to 5 mol% with no decrease in yield or enantioselectivity of **2a** ([Table 1](#tab1){ref-type="table"}, entry 8). To further enhance the enantioselectivity, structural modification of the chiral acid catalyst was examined. Chiral phosphoric acids and their derivatives were commonly modified at structurally adjustable sites, such as the introduction of substituent G at 3,3′-positions, the chiral framework, and the acidic functionality. Among the approaches reported, 3,3′-substituent G has been widely investigated. However, the enantioselectivity could not be improved despite extensive screening for substituents G in the present reaction.[@cit17] The screening for the chiral frameworks was also unsuccessful.[@cit17] The anthryl substituent and the BINOL framework were a worthwhile combination in terms of enantioselectivity; however, these still gave unsatisfactory results (80% ee). We then turned our attention to the acidic functionality. Although it has been investigated in terms of an increase in catalyst acidity,[@cit18] it has been anticipated that the introduction of a suitable substituent to the acidic functionality would be an intriguing approach for enantioselectivity enhancement.[@cit18d] Indeed, as shown in entries 9--11, [Table 1](#tab1){ref-type="table"}, marked influence on the enantioselectivity was noted by changing the substituent at the sulfonamide moiety.[@cit19] Although the introduction of a longer perfluoroalkyl chain, namely, nonafluorobutyl, instead of trifluoromethyl, resulted in the reduction of the enantioselectivity ([Table 1](#tab1){ref-type="table"} entry 9), the catalyst having a perfluoroaryl group enhanced the enantioselectivity ([Table 1](#tab1){ref-type="table"}, entries 10 and 11) and, in particular, the perfluoro-2-naphthyl substituent markedly improved the enantioselectivity. Further reduction of the temperature to --60 °C resulted in the formation of **2a** with the highest enantioselectivity (95% ee) among the conditions tested ([Table 1](#tab1){ref-type="table"}, entry 12). The absolute configuration of **2a** was determined to be (*R*) by derivatization into a structurally known compound.[@cit20]

###### Screening for reaction conditions and catalyst in intramolecular allylic substitution reaction[^*a*^](#tab1fna){ref-type="fn"}

  ![](c8sc01942h-u1.jpg){#ugr1}                                                                                                            
  ------------------------------------------------------------------------------------ -------------- ------------ --------------- ------- ------
  1                                                                                    (*R*)-**4**    CH~2~Cl~2~   RT, 24 h        Trace   n.d.
  2                                                                                    (*R*)-**3a**   CH~2~Cl~2~   RT, 0.5 h       92      27
  3                                                                                    (*R*)-**3a**   CHCl~3~      RT, 0.5 h       95      36
  4                                                                                    (*R*)-**3a**   Toluene      RT, 24 h        34      24
  5                                                                                    (*R*)-**3a**   MeCN         RT, 0.5 h       72      \<1
  6                                                                                    (*R*)-**3a**   CHCl~3~      --40 °C, 24 h   29      80
  7[^*d*^](#tab1fnd){ref-type="table-fn"}                                              (*R*)-**3a**   CHCl~3~      --40 °C, 6 h    95      79
  8[^*d*^](#tab1fnd){ref-type="table-fn"} ^,^[^*e*^](#tab1fne){ref-type="table-fn"}    (*R*)-**3a**   CHCl~3~      --40 °C, 24 h   94      80
  9[^*d*^](#tab1fnd){ref-type="table-fn"} ^,^[^*e*^](#tab1fne){ref-type="table-fn"}    (*R*)-**3b**   CHCl~3~      --40 °C, 24 h   79      65
  10[^*d*^](#tab1fnd){ref-type="table-fn"} ^,^[^*e*^](#tab1fne){ref-type="table-fn"}   (*R*)-**3c**   CHCl~3~      --40 °C, 24 h   92      83
  11[^*d*^](#tab1fnd){ref-type="table-fn"} ^,^[^*e*^](#tab1fne){ref-type="table-fn"}   (*R*)-**3d**   CHCl~3~      --40 °C, 24 h   96      89
  12[^*d*^](#tab1fnd){ref-type="table-fn"}                                             (*R*)-**3d**   CHCl~3~      --60 °C, 48 h   85      95

^*a*^Unless otherwise noted, all reactions were carried out using 0.01 mmol of (*R*)-**3** or (*R*)-**4** (10 mol%), 0.1 mmol of (*E*)-**1a**, and MS 4A (50 mg) in the indicated solvent (1.0 mL).

^*b*^Isolated yield.

^*c*^ee was determined by chiral stationary phase HPLC analysis.

^*d*^MS 4A was used.

^*e*^5 mol% of (*R*)-**3** was used.

Scope of substrates
-------------------

The substrate scope of the present transformation was demonstrated in the reaction using a series of aryl- or alkynyl-substituted bis-trichloroacetimidate **1** and optimized catalyst (*R*)-**3d**. The reactivity of **1** was markedly dependent on the properties of the R substituent, such as the electronic nature and the steric hindrance. As expected, the reaction of the substrate having an electron-donating group at the aryl moiety proceeded rapidly. In contrast, the substrate having an electron-withdrawing group at the aryl moiety decelerated the reaction markedly. Therefore, the reaction temperature was optimized for each substrate. As shown in [Table 2](#tab2){ref-type="table"}, substrate **1** having a *meta*- or *para*-substituted aryl moiety underwent the intramolecular substitution reaction efficiently under the optimized reaction conditions, affording S~N~2′-substituted product **2** in good yield with high enantioselectivity (around 90% ee), irrespective of the electronic nature of the aryl moieties (entries 1--7). In contrast, *ortho*-substitution at the aryl moiety had a negative effect on the enantioselectivity or the chemical yield (entries 8--10). In particular, an *ortho*-methyl substituent retarded the reaction significantly and only a trace amount of the desired product was formed (entry 9).[@cit21] Although an alkynyl substituent exhibited moderate enantioselectivity (entry 12), substrates having a fused aryl, namely, 2-naphthyl (entry 11), and thiophen-3-yl (entry 13) as the heteroaryl compounds were also applicable to the present reaction, affording the substitution products in good enantioselectivities. In contrast, the use of a substrate having an alkyl substituent, such as a benzyl group (R = Bn), resulted in no reaction. The substrate-dependent reactivity observed in the present reaction suggests that the conjugation between the R substituent and the allylic moiety is essential for the progress of the reaction.

###### Substrate scope of enantioselective intramolecular S~N~2′ reaction[^*a*^](#tab2fna){ref-type="fn"}

  ![](c8sc01942h-u2.jpg){#ugr2}                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------- ------- -----
  1[^*d*^](#tab2fnd){ref-type="table-fn"}    **b**: 4-MeOC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --60 °C, 12 h   98      79
  2[^*d*^](#tab2fnd){ref-type="table-fn"}    **c**: 4-MeC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  --60 °C, 12 h   96      90
  3                                          **d**: 4-ClC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  --50 °C, 48 h   90      91
  4                                          **e**: 3-MeOC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --50 °C, 12 h   90      90
  5                                          **f**: 3-MeC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  --60 °C, 48 h   97      91
  6                                          **g**: 3-ClC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  --40 °C, 36 h   88      88
  7                                          **h**: 3-CF~3~C~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               --40 °C, 48 h   86      89
  8                                          **i**: 2-MeOC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 --40 °C, 12 h   90      60
  9                                          **j**: 2-MeC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  rt, 24 h        Trace   ---
  10                                         **k**: 2-FC~6~H~4~--                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   --20 °C, 12 h   87      87
  11[^*d*^](#tab2fnd){ref-type="table-fn"}   **l**: 2-Naphthyl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      --60 °C, 12 h   85      86
  12                                         **m**: Ph--C0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000C--   --40 °C, 48 h   55      60
  13[^*d*^](#tab2fnd){ref-type="table-fn"}   **n**: Thiophen-3-yl                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   --60 °C, 8 h    95      91

^*a*^Unless otherwise noted, all reactions were carried out using 0.01 mmol of (*R*)-**3d** (10 mol%), 0.1 mmol of (*E*)-**1**, and MS 4A (50 mg) in chloroform (1.0 mL).

^*b*^Isolated yield.

^*c*^ee was determined by chiral stationary phase HPLC analysis.

^*d*^5 mol% of (*R*)-**3d** was used.

Derivatization of product
-------------------------

The derivatization of product **2a** was next demonstrated ([Scheme 2](#sch2){ref-type="fig"}). Under acidic conditions, the oxazoline moiety of product **2a** readily underwent partial hydrolysis, affording corresponding amide **5**. Subsequent treatment with lithium hydroxide furnished cyclic carbamate **6** in good yield ([Scheme 2a](#sch2){ref-type="fig"}). Under basic conditions, the complete hydrolysis of the oxazoline moiety of product **2a** took place and this was followed by protection at the nitrogen atom of resultant amino alcohol **7** with Boc group to furnish alcohol **8** in good yield ([Scheme 2b](#sch2){ref-type="fig"}). During the course of these derivatizations, no loss of enantiomeric purity was observed in both cases.

![Derivatization of product **2a**.](c8sc01942h-s2){#sch2}

Experimental elucidation of reaction mechanisms
-----------------------------------------------

### Mechanistic study 1 (using deuterated substrate)

As high enantioselectivities were achieved in the intramolecular S~N~2′ reaction using chiral phosphoramide catalyst **3d**, the mechanistic elucidation of the present reaction became our next focus. At the outset of mechanistic studies, we employed enantiomerically pure bis-trichloroimidate (*S*)-*d***-1a**, in which deuterium was introduced at the methylene position near the leaving group,[@cit22] to identify the concerted process ([Scheme 3](#sch3){ref-type="fig"}). In the proposed deuterated substrate study, the stereochemical relationship between the chirality at the deuterated carbon of starting (*S*)-*d***-1a** and the geometry of the migrated double bond, coupled with the newly generated quaternary stereogenic center, conveys crucial information of whether the reaction proceeds through the S~N~2′ or S~N~1 mechanism. As shown in [Scheme 3](#sch3){ref-type="fig"}, enantiomerically enriched (*Z*)-*d***-2a** (93% ee) was obtained in high geometrical selectivity, clearly suggesting that the reaction proceeded through the concerted mechanism, namely, the S~N~2′ pathway, and not the stepwise mechanism by way of an allyl cation intermediate. More importantly, product (*Z*)-*d***-2a** had (*R*)-absolute configuration with 93% ee. The observed stereochemical relationship indicates that the nucleophilic imidate and the leaving one are in an *anti*-relationship **C**, as illustrated in [Scheme 3](#sch3){ref-type="fig"}, and hence the *anti*-S~N~2′ pathway is considered to be the rational mechanism of the present substitution reaction.

![Mechanistic study using *enantio*-enriched deuterated substrate (*S*)-*d***-1a**.](c8sc01942h-s3){#sch3}

### Mechanistic study 2 (NMR monitoring of reaction mixture)

Recently, some examples have emerged indicating that the chiral phosphoric acid undergoes a substitution reaction with the substrate, where the acid catalyst functions as a nucleophile, to generate the corresponding phosphate ester as the reactive intermediate.[@cit12] As depicted in [Scheme 4](#sch4){ref-type="fig"}, in principle, phosphorimidate **B**, which was generated through the S~N~2 reaction of catalyst **3** with **1** at the terminal allylic position far from R group, might be involved as the reactive intermediate in the present reaction. Because the S~N~2 reaction, giving **B** with inversion at the substitution site, followed by the *syn*-S~N~2′ reaction through **D**, namely, the net *anti*-S~N~2′ pathway, also fulfils the requirement of the experimental evidence obtained in the deuterated substrate experiment as shown in [Scheme 3](#sch3){ref-type="fig"}. Considering recent reports[@cit12] and the sequential S~N~2/*syn*-S~N~2′ pathway, ^31^P NMR monitoring was conducted to detect the formation of phosphorimidate **B**. NMR monitoring was performed using 10 mol% of catalyst **3c** and **1a** in the presence of MS 4A in CDCl~3~ at --40 °C ([Fig. 2](#fig2){ref-type="fig"}).[@cit23] At the beginning of the monitoring, phosphorimidate **B** (R = Ph, Rf = C~6~F~5~) was detected ([Fig. 2a](#fig2){ref-type="fig"}),[@cit24] although phosphoramide catalyst **3c** was not completely transformed into **B** and a considerable amount of **3c** remained even after 4 h ([Fig. 2b](#fig2){ref-type="fig"}).[@cit25]

![Sequential S~N~2/*syn*-S~N~2′ mechanism as a plausible pathway for the formal *anti*-S~N~2′ process.](c8sc01942h-s4){#sch4}

![^31^P NMR spectra for the reaction of **1a** catalyzed by (*R*)-**3c** at --40 °C after (a) 15 min and (b) 4 h.](c8sc01942h-f2){#fig2}

### Mechanistic study 3 (substrate having a different leaving group)

If the reaction would proceed through phosphorimidate **B**, the leaving group, namely, the imidate moiety far from R group, is not involved in the *enantio*-determining step (EDS). This is because the quaternary stereogenic center is formed from **B**, in which the imidate leaving group has been cleaved off from the substrate. We then turned our attention to the use of substrate **9** having a different leaving group (*LG*). As shown in [Table 3](#tab3){ref-type="table"}, *LG* significantly influenced the enantioselectivity of product **2a**.[@cit26] These results reveal that the leaving group is involved in the EDS and hence phosphorimidate **B** would not be an active intermediate in the actual reaction pathway.

###### Substrate having different leaving group[^*a*^](#tab3fna){ref-type="fn"}

  Entry                                     *LG*                            Substrate   Conditions      Yield[^*b*^](#tab3fnb){ref-type="table-fn"} (%)   ee[^*c*^](#tab3fnc){ref-type="table-fn"} (%)
  ----------------------------------------- ------------------------------- ----------- --------------- ------------------------------------------------- ----------------------------------------------
  1[^*d*^](#tab3fnd){ref-type="table-fn"}   ![](c8sc01942h-u3.jpg){#ugr3}   **1a**      --40 °C, 24 h   92                                                83
  2                                         ![](c8sc01942h-u4.jpg){#ugr4}   **9a**      --40 °C, 18 h   90                                                60
  3                                         ![](c8sc01942h-u5.jpg){#ugr5}   **9b**      --40 °C, 20 h   90                                                31
  4                                         ![](c8sc01942h-u6.jpg){#ugr6}   **9c**      rt, 24 h        ND[^*e*^](#tab3fne){ref-type="table-fn"}          ---
  ![](c8sc01942h-u7.jpg){#ugr7}                                                                                                                           

^*a*^Unless otherwise noted, all reactions were carried out using 0.005 mmol of (*R*)-**3c** (10 mol%), 0.05 mmol of (*E*)-**9** or (*E*)-**1a**, and MS 4A (25 mg) in chloroform (0.5 mL).

^*b*^Isolated yield.

^*c*^ee was determined by chiral stationary phase HPLC analysis.

^*d*^5 mol% of (*R*)-**3c** was used.

^*e*^Not detected.

Theoretical studies of reaction mechanisms
------------------------------------------

As the concerted *anti*-S~N~2′ pathway is supported by the above experimental studies of the mechanistic elucidation, we further conducted DFT calculation to confirm the actual reaction pathway and elucidate the mechanism of the concerted *anti*-S~N~2′ process and the origin of the stereochemical outcome.

### Model system

To identify the energy profile of the present S~N~2′ reaction, the model system of phosphoramide **3e** and standard substrate **1a** was employed to streamline the calculation ([Scheme 5](#sch5){ref-type="fig"}).[@cit27] In the model system, phosphoramide catalyst **3** was simplified to **3e** having phenylsulfonamide instead of perfluoroarylsulfonamide and a biphenyl backbone generating an axially chiral structure in which (*R*)-chirality was introduced in accordance with the actual reaction system. In addition, the generation of major enantiomer (*R*)-**2a** was calculated as observed in the actual stereochemical outcome. For the calculation, the energy profile of the sequential S~N~2/*syn*-S~N~2′ pathway, namely, the net *anti*-S~N~2′, involving phosphorimidate **B~model~** as the intermediate was also considered and compared with that of the concerted *anti*-S~N~2′ pathway that is supported by the above experimental results.[@cit28] All calculations were performed with the Gaussian 16 package (Revision B.01).[@cit29] Geometries were optimized and characterized using frequency calculations at the B97D/6-31G(d) level.[@cit30],[@cit31] Gibbs free energies in the solution phase were calculated using single-point energy calculations at the same level according to the PCM solvation model (chloroform: *ε* = 4.9) for the optimized structures.[@cit32]

![Model system for calculation.](c8sc01942h-s5){#sch5}

First, the energy profile of the sequential S~N~2/*syn*-S~N~2′ (net *anti*-S~N~2′) pathway was identified to confirm whether intermediate **B~model~** undergoes further *syn*-S~N~2′ reaction or not ([Fig. 3](#fig3){ref-type="fig"}), because this sequential pathway was experimentally proven to be negative. In accordance with the experimental confirmation of the structure of **B**,[@cit24] the formation of the allylic phosphate ester was considered as the first S~N~2 step. Therefore, as shown in **CP-1**, the substitution reaction was initiated through the protonation of imidate nitrogen N~*LG*~ of the leaving group by the H--N moiety of **3e**. The following S~N~2 reaction proceeded *via* transition state **TS-1** in which the phosphoryl oxygen attacked the carbon having the leaving group to generate phosphate ester intermediate **INT-1**. Transition state analysis of the subsequent *syn*-S~N~2′ step was thoroughly conducted using the phosphate ester **INT-2** (=**B~model~**).[@cit26] As a result, in contrast to the relatively small energy barrier of **TS-1** (the first S~N~2 step), **TS-2** (the second *syn*-S~N~2′ step) exhibited a larger energy barrier than **TS-1**. Based on the present energy profile of the sequential S~N~2/*syn*-S~N~2′ pathway, the initial S~N~2 step was considered to be a catalyst deactivation process. Indeed, as shown in [Table 2](#tab2){ref-type="table"}, entry 9, in the reaction of substrate **1j** having an *ortho*-methylphenyl substituent, a significant amount of phosphate ester was detected by NMR monitoring[@cit21] and a trace amount of the desired product was formed.

![Energy profile of the sequential S~N~2/*syn*-S~N~2′ (net *anti*-S~N~2′) pathway for the model reaction. The potential energy for the sum of **1a** and **3e** was set to zero. Geometries were optimized and characterized using frequency calculations at the B97D/6-31G(d) level. Gibbs free energies (kcal mol^--1^) in solution phase were calculated using single-point energy calculations at the same level as those for the optimized structures according to the SCRF method based on PCM (CHCl~3~).](c8sc01942h-f3){#fig3}

The energy profile of the concerted *anti*-S~N~2′ pathway for the model system is shown in [Fig. 4](#fig4){ref-type="fig"}. In order to identify the transition state of the concerted *anti*-S~N~2′ pathway, a variety of initial structures were thoroughly generated, in which catalyst H--N protonated the imidate nitrogen N~*LG*~ of the leaving group, analogous to **CP-1** ([Fig. 3](#fig3){ref-type="fig"}). However, all attempts to find the transition states of the concerted *anti*-S~N~2′ pathway were unsuccessful and resulted in the transition states of the S~N~2 reaction of the phosphoryl oxygen at the carbon atom having the leaving group, analogous to **TS-1** ([Fig. 3](#fig3){ref-type="fig"}). Taking these unsuccessful results into consideration, we surmised that the hydrogen bond acceptor site generated on the catalyst conjugate base is too far to interact with the proton attached to nucleophilic nitrogen N~*Nu*~. We therefore attempted to switch the acidic site, namely, the hydrogen bond donor site, of **3e**. Proton shift from the initial H--N form to the phosphoryl oxygen generated H--O acid of the catalyst.[@cit33] As shown in **CP-3**, the generated H--O acid protonates nitrogen atom N~*LG*~ to activate the leaving group, whereas the oxygen atom of the sulfonamide moiety interacts with the hydrogen atom to enhance the nucleophilicity of nitrogen atom N~*Nu*~. Because the bond connection sequence was elongated, N*~Nu~*--H···O0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000S--N0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 1111111111111111111111111111111111 1111111111111111111111111111111111 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000 0000000000000000000000000000000000P--O--H···N~*LG*~, the concerted *anti*-S~N~2′ pathway became feasible as a rational reaction mechanism. In fact, after thorough screening for the transition states, corresponding **TS-3** was successfully calculated. Careful analysis of **TS-3** indicates that the reaction does not proceed in a completely concerted fashion because the leaving group has been cleaved off prior to the C^3^--N~*Nu*~ bond formation. In **TS-3**, the cleaving C^1^--O bond of the leaving group elongates to 1.97 Å, whereas the distance between C^3^ and N~*Nu*~ is 2.89 Å and still too large to form a C^3^--N~*Nu*~ bond. However, subsequent analysis of the intrinsic reaction coordinate (IRC) from **TS-3** revealed the formation of ternary associated complex **CP-4** consisting of product **2a**, catalyst **3e**, and trichloroacetamide. Consequently, the present reaction mechanism is considered to proceed in a synchronous *anti*-S~N~2′ fashion rather than the ideal concerted pathway. More importantly, the comparable energy levels between **TS-3** ([Fig. 4](#fig4){ref-type="fig"}) and **TS-1** ([Fig. 3](#fig3){ref-type="fig"}) imply that these pathways compete with each other. In fact, the formation of phosphate ester **B** was observed during the course of NMR monitoring, in which the leaving group was cleaved off from the reaction system prior to the C^3^--N~*Nu*~ bond formation step, whereas enantioselectivity was markedly dependent on the leaving group and hence the leaving group was considered to be involved in EDS, namely, the C^3^--N~*Nu*~ bond formation step. Although there seems to be a contradiction, these results are well rationalized if these pathways would take place in parallel, as evaluated in the calculation.

![Energy profile of the synchronous *anti*-S~N~2′ pathway for the model reaction. The potential energy for the sum of **1a** and **3e** was set to zero. Geometries were optimized and characterized using frequency calculations at the B97D/6-31G(d) level. Gibbs free energies (kcal mol^--1^) in solution phase were calculated using single-point energy calculations at the same level as those for the optimized structures according to the SCRF method based on PCM (CHCl~3~).](c8sc01942h-f4){#fig4}

### Real system

The product formation pathway was clarified on the basis of the experimental studies and the energy profiles of the model calculations. We next turned our attention to the elucidation of the origin of the stereochemical outcome at the EDS, in particular, the intriguing substituent effect at the catalyst sulfonamide unit. As shown in [Table 1](#tab1){ref-type="table"}, entries 8--11, the substituent at the sulfonamide unit influenced the enantioselectivity. In order to gain an insight into the origin of the stereochemical outcome as well as the substituent effect at the catalyst sulfonamide unit, we calculated the transition state of the EDS, namely, the synchronous *anti*-S~N~2′ step, using substrate **1a** and (*R*)-**3d**, instead of simplified **3e**. The calculated transition states for both major and minor pathways of the reaction using **1a** are shown in [Fig. 5](#fig5){ref-type="fig"}.[@cit34] The energy difference between these two transition states is 1.5 kcal mol^--1^ with the one resulting in (*R*)-**2a** through **TS-R** being the energetically favoured one ([Fig. 5a](#fig5){ref-type="fig"}). The result of the calculations is consistent with the experimental finding that (*R*)-**2a** is the major enantiomer in the reaction of **1a** catalyzed by (*R*)-**3d**.

![Transition states of synchronous *anti*-S~N~2′ reaction of **1a** catalyzed by (*R*)-**3d**. Geometries were optimized and characterized using frequency calculations at the B97D/6-31G(d) level. Relative Gibbs free energies (kcal mol^--1^) obtained by single-point energy calculations at the same level as those for the optimized structures with the SCRF method based on PCM (CHCl~3~) are shown. (a) Transition state for the formation of (*R*)-**2a**. (b) Transition state for the formation of (*S*)-**2a**.](c8sc01942h-f5){#fig5}

In both transition states, the relative location of substrate **1a** and catalyst (*R*)-**3d** is defined by three-point hydrogen bonds. The H--O acid moiety of **3d** protonates nitrogen atom N~*LG*~ of the leaving group, whereas the oxygen atom of the sulfonamide moiety interacts with the hydrogen atom attached to nucleophilic nitrogen atom N~*Nu*~. These two hydrogen bonds are essential to accelerate the *anti*-S~N~2′ reaction. Meanwhile, an additional non-classical C--H···O hydrogen bond between the allylic hydrogen and the phosphoryl oxygen is formed in both transition structures.[@cit35] These three-point hydrogen bonding interactions, coupled with the use of a geometrically defined substrate, are the key to achieving the high enantioselectivity because the distinct discrimination of the substituents attached to the double bond is achieved by the anthryl and sulfonamide substituents of catalyst (*R*)-**3d**.[@cit36] Indeed, when the location of the nucleophilic N~*Nu*~ is fixed at the left front side, as shown in [Fig. 5](#fig5){ref-type="fig"}, the positions of the phenyl substituent and the leaving group are switched in these two transition states. In transition state **TS-R** ([Fig. 5a](#fig5){ref-type="fig"}) affording the major enantiomer, the phenyl substituent is oriented to occupy the sterically less hindered back side and further stabilizes this transition state through the T-shaped C--H···π interaction[@cit37],[@cit38] with the left side anthryl substituent of the catalyst. In transition state **TS-S**, the T-shaped C--H···π interaction also takes place between the allylic hydrogen of the substrate and the left side anthryl substituent of the catalyst ([Fig. 5b](#fig5){ref-type="fig"}). However, the phenyl substituent that locates to the right front side induces repulsive interaction with the right side anthryl and perfluoronaphthyl substituents of the catalyst. The substituent effect of the sulfonamide unit of the catalyst, as shown in [Table 1](#tab1){ref-type="table"}, entries 8--11, is also well rationalized on the basis of these transition structures. This is because in **TS-S**, the phenyl substituent locates closely to the sulfonamide unit of the catalyst, inducing a repulsive interaction between them. The significant effect of the leaving group, as shown in [Table 3](#tab3){ref-type="table"}, entry 3 in particular (introduction of the phenethyl substituent at the imidate nitrogen atom), is also rationalized on the basis of these transition states in which energetically favourable **TS-R** is destabilized by the steric congestion induced between the right side anthryl substituent of the catalyst and the modified leaving group.

Conclusions
===========

We have accomplished an enantioselective intramolecular *anti*-S~N~2′ cyclization reaction for the construction of a quaternary stereogenic center through the activation of the leaving group using a chiral Brønsted acid catalyst. Taking advantage of the present allylic substitution protocol not only for regioselective bond formation at the multi-substituted site but also for controlling the stereochemical outcome under acidic conditions, the reaction affords synthetically useful amino alcohol derivatives having a tetra-substituted carbon center in a highly enantioselective manner in most cases. To improve the enantioselectivity, modification of the sulfonamide unit of the phosphoramide catalyst was found to be an efficient approach. Experimental and theoretical studies elucidated the reaction pathway and the origin of the stereochemical outcomes at the generated quaternary stereogenic center. Experimental elucidation of the reaction mechanism suggests that the reaction proceeds through a concerted *anti*-S~N~2′ pathway, although the formation of the phosphorimidate ester, which is considered to deactivate the catalyst, was observed during ^31^P NMR monitoring of the reaction. The Gibbs free energy profile formulated by the theoretical calculations indicates that the reaction proceeds through a synchronous *anti*-S~N~2′ pathway rather than an ideal concerted pathway. Structural analysis of real model transition states at the *enantio*-determining step revealed that the distinct discrimination of the allyl substrate is achieved by the anthryl and sulfonamide substituents of the catalyst through the three-point hydrogen bonding interactions and the T-shaped C--H···π interactions, because of using a geometrically defined allylic substrate. Further studies of the development of enantioselective allylic substitution reactions using other types of nucleophiles are underway.
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